Related Experiment Video
Updated: Jun 24, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
Modulation of in vitro murine B-lymphocyte response by curcumin
D Decoté-Ricardo1, K K F Chagas, J D B Rocha
1Departamento de Imunologia, Instituto de Microbiologia Prof. Paulo de Góes, Universidade Federal do Rio de Janeiro, CCS, Bloco I, sala I2-062, Ilha do Fundão, 21944-570 Rio de Janeiro, RJ, Brazil.
Summary
Curcumin, a compound from turmeric, inhibits B cell proliferation and IgM secretion by blocking key signaling pathways like ERK, IkappaB, and p38. This suggests curcumin
Area of Science:
- Immunology
- Pharmacology
- Natural Products
Background:
- Curcumin, derived from turmeric (Curcuma longa), is known for anti-inflammatory and anti-tumor properties.
- Its effects on normal immune cells, particularly B cells, require further investigation.
Purpose of the Study:
- To investigate the inhibitory effects of curcumin on normal murine splenic B cell responses.
- To elucidate the intracellular signaling pathways affected by curcumin in B cells.
Main Methods:
- Purified splenic B cells from BALB/c mice were stimulated with Toll-like receptor (TLR) ligands (LPS, CpG) and other stimuli.
- Proliferation and IgM secretion were measured.
- Intracellular signaling events, including calcium levels, protein phosphorylation (ERK, IkappaB, p38), and NF-kappaB nuclear translocation, were analyzed using Western blotting.
Main Results:
- Curcumin inhibited the proliferative response of B cells stimulated by LPS and CpG oligodeoxynucleotides.
- LPS-induced IgM secretion was suppressed by curcumin.
- Curcumin inhibited the phosphorylation of ERK, IkappaB, and p38, and decreased nuclear NF-kappaB levels, but did not affect calcium levels or responses to T-independent stimuli.
Conclusions:
- Curcumin acts as an inhibitor of signaling pathways activated by TLR ligands in B cells.
- These findings indicate that curcumin has the potential to be a pharmacological inhibitor of B cell activation.
